Literature DB >> 25813805

Alveolar bone dynamics in osteoporotic rats treated with raloxifene or alendronate: confocal microscopy analysis.

Gabriel Ramalho-Ferreira1, Leonardo Perez Faverani1, Gustavo Augusto Grossi-Oliveira1, Tetuo Okamoto1, Roberta Okamoto2.   

Abstract

In this study, the characteristics of the alveolar bone of rats with induced osteoporosis were examined. Thirty-two rats were divided into four groups according to the induction of osteoporosis and drugs administered: OG, osteoporotic rats without treatment (negative control); SG, rats which underwent sham surgery ovariectomy (SHAM); alendronate (AG), osteoporotic rats treated with alendronate; and RG, osteoporotic rats treated with raloxifene (RG). On the 8th day after ovariectomy and SHAM surgeries, drug therapy was started with AG or RG. On the 52nd day, 20 mg/kg calcein was administered to all of the rats, and on the 80th day, 20 mg/kg alizarin red was administered. Euthanasia was performed on the 98th day. The bone area marked by fluorochromes was calculated and data were subjected to two-way ANOVA test and Tukey's post-hoc test (p < 0.05). The comparison of the induced osteoporosis groups showed no statistically significant differences in bone turnover only between RG and SG (p = 0.074) and AG and OG (p = 0.138). All other comparisons showed significant differences (p < 0.001). The largest bone turnover was observed in RG and SG groups. RG was the medication that improved the dynamics of the alveolar bone of rats with induced osteoporosis, resembling that of healthy rats.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25813805     DOI: 10.1117/1.JBO.20.3.038003

Source DB:  PubMed          Journal:  J Biomed Opt        ISSN: 1083-3668            Impact factor:   3.170


  6 in total

1.  Raloxifene but not alendronate can compensate the impaired osseointegration in osteoporotic rats.

Authors:  Leonardo Perez Faverani; Tárik Ocon Braga Polo; Gabriel Ramalho-Ferreira; Gustavo Antonio Correa Momesso; Jaqueline Suemi Hassumi; Ana Cláudia Rossi; Alexandre Rodrigues Freire; Felippe Bevilacqua Prado; Eloá Rodrigues Luvizuto; Reinhard Gruber; Roberta Okamoto
Journal:  Clin Oral Investig       Date:  2017-03-29       Impact factor: 3.573

2.  Effect of antiresorptive drugs in the alveolar bone healing. A histometric and immunohistochemical study in ovariectomized rats.

Authors:  Gabriel Ramalho-Ferreira; Leonardo Perez Faverani; Gustavo Antonio Correa Momesso; Eloá Rodrigues Luvizuto; Igor de Oliveira Puttini; Roberta Okamoto
Journal:  Clin Oral Investig       Date:  2016-07-27       Impact factor: 3.573

3.  Losartan improves alveolar bone dynamics in normotensive rats but not in hypertensive rats.

Authors:  Gabriel Mulinari-Santos; Jaqueline Silva Dos Santos; Letícia Pitol Palin; Ana Cláudia Ervolino da Silva; Cristina Antoniali; Leonardo Perez Faverani; Roberta Okamoto
Journal:  J Appl Oral Sci       Date:  2019-10-07       Impact factor: 2.698

4.  Bone Regeneration Assessment of Polycaprolactone Membrane on Critical-Size Defects in Rat Calvaria.

Authors:  Ana Paula Farnezi Bassi; Vinícius Ferreira Bizelli; Tamires Mello Francatti; Ana Carulina Rezende de Moares Ferreira; Járede Carvalho Pereira; Hesham Mohammed Al-Sharani; Flavia de Almeida Lucas; Leonardo Perez Faverani
Journal:  Membranes (Basel)       Date:  2021-02-09

5.  Beta tricalcium phosphate, either alone or in combination with antimicrobial photodynamic therapy or doxycycline, prevents medication-related osteonecrosis of the jaw.

Authors:  Henrique Hadad; Laís Kawamata de Jesus; Ana Flávia Piquera Santos; Henrique Rinaldi Matheus; Letícia Gabriella de Souza Rodrigues; Pier Paolo Poli; Elcio Marcantonio Junior; Fernando Pozzi Semeghini Guastaldi; Carlo Maiorana; Juliano Milanezi de Almeida; Roberta Okamoto; Francisley Ávila Souza
Journal:  Sci Rep       Date:  2022-10-03       Impact factor: 4.996

6.  A SERM increasing the expression of the osteoblastogenesis and mineralization-related proteins and improving quality of bone tissue in an experimental model of osteoporosis.

Authors:  Fernanda Costa Yogui; Gustavo Antonio Correa Momesso; Leonardo Perez Faverani; Tarik Ocon Braga Polo; Gabriel Ramalho-Ferreira; Jaqueline Suemi Hassumi; Ana Cláudia Rossi; Alexandre Rodrigues Freire; Felippe Bevilacqua Prado; Roberta Okamoto
Journal:  J Appl Oral Sci       Date:  2018-05-07       Impact factor: 2.698

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.